Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | BCL6 | P41182 | 5/20 | 0.38 |
| ▸ | PKM | P14618 | 3/20 | 0.37 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.37 |
| ▸ | BRPF1 | P55201 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24865602 | 0.85 | SMN1; SMN2 (0.47) | SMN1; SMN2GAAALDH1A1TP53HSD17B10 | |
| SCHEMBL31123224 | 0.85 | SMN1; SMN2 (0.47) | SMN1; SMN2GAAALDH1A1TP53HSD17B10 | |
| SCHEMBL24865793 | 0.84 | ALDH1A1 (0.41) | SMN1; SMN2ALDH1A1TP53LMNAMAPT | |
| SCHEMBL31123346 | 0.84 | ALDH1A1 (0.35) | SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL24865689 | 0.84 | ALDH1A1 (0.35) | SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL24865642 | 0.83 | BCL6 (0.47) | SMN1; SMN2GAAALDH1A1TP53HSD17B10 | |
| SCHEMBL24865764 | 0.80 | SMN1; SMN2 (0.46) | SMN1; SMN2GAAALDH1A1TP53HSD17B10 | |
| SCHEMBL24865236 | 0.79 | SMN1; SMN2 (0.49) | SMN1; SMN2GAAALDH1A1TP53HSD17B10 | |
| SCHEMBL30336935 | 0.79 | SMN1; SMN2 (0.49) | SMN1; SMN2GAAALDH1A1TP53HSD17B10 | |
| SCHEMBL24865299 | 0.78 | BCL6 (0.50) | SMN1; SMN2GAAALDH1A1TP53HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240327393-A1 | FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd. (KY) | 2024-10-03 | — | — | US | disclosed |
| CN-117999259-A | Iron death modulators, their preparation and use | 维泰瑞隆有限公司 | 2024-05-07 | — | — | CN | disclosed |
| WO-2023280296-A1 | FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd. (KY) | 2023-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240327393-A1 | FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF | AIFM2, GPX1, GPX4 | SMN1; SMN2 1657/4885GAA 861/4885ALDH1A1 1306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.